Polfa shareholders mull euro 10.5 million plant investment

"This production is necessary for the holding and it will well supplement the production profile. Before we agree to engaging large sums of money, we have to be sure that drugs were registered in Poland and the venture is feasible," said Andrzej Kleszczewski, president of Polish Pharmaceutical Holding (PHF), which is the main shareholder of Polfa. Andrzej Tyrała, president of the company, estimates value of the investment at euro 10.5 million, and the project will be financed solely by the firm. "I hope we will launch industrial scale production in Q4 2007," said Polfa's CEO. Polfa is currently waiting for the registration of three new products, while it holds the right to produce six more drugs for which it has acquired licenses. (Puls Biznesu, pp. 1, 7) M.M.